valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

EASTMAN CHEMICAL CO (EMN) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$60.00 ComplexityHigh Updated
$54.00 $119.00
bear $54.00 base $100.00 bull $119.00 margin of safety $60.00 market price* $62.33
Business condition attached to the margin of safety FY2026 results show capital spending fell to roughly $400 million from $546 million, as guided in Eastman's FY2025 10-K, mostly as maintenance spending, with no new impairment against the Advanced Materials reporting unit that Eastman's auditors flagged this year as requiring unusually judgment-heavy fair-value testing.
Eastman Chemical makes and sells specialty and commodity chemicals used across everyday products: Tritan copolyester in reusable bottles and eyewear, Saflex interlayers in automotive and architectural glass, performance films, coatings and adhesives, acetyl chemicals, and acetate tow used in cigarette filters. Results move with the broader chemicals cycle — feedstock costs, and industrial demand from automotive, construction and consumer durables. 2025 was a weak year: earnings before interest and taxes fell 39% to $776 million, and owner earnings (the cash the business generates after the spending genuinely needed to keep current operations running, before the extra spending it chooses to make to grow) came to about $4.83 per share, down from $5.75 the year before. Most of that decline traces to one segment: Fibers, which houses acetate tow, saw sales drop 20% and earnings drop 38% as customers worked down tow inventories and tariff-related uncertainty weighed on textile demand into Europe and Asia. The Advanced Materials segment — home to automotive interlayers, performance films, and the company's large new plastic-to-plastic recycling investment — also softened, with earnings down 25-28% on weaker demand in interlayers and films. We value the business on its owner earnings, not on 2025's depressed level. Looking across the last ten years — which include strong years (2016-2019, 2021), the 2020 pandemic dip, and the sharper 2022-2023 industry-wide destocking trough — owner earnings per share ranged from about $3.00 to $7.30, with a typical (median) level of roughly $5.80. We use that typical level as the foundation, because valuing the business off a single weak year would simply chase the stock down with the cycle. Two judgment calls carried over from our own review of the data: first, Eastman has put more cash into its pension plans than it has expensed through the income statement in every one of the last ten years, so we treat that gap as a real recurring cost rather than a reversing timing swing. Second, capital spending has run well above its normal historical share of revenue since 2022 because of a large, first-of-its-kind plastic-to-plastic recycling facility at Kingsport, Tennessee; we treated spending above a normal maintenance level as discretionary growth investment, which means the payoff from that investment is not yet proven in the numbers. On owner earnings, 2025 was down about 16% from 2024 — a real decline, not a rounding error. We do not assume that reverses on hope. What we can point to is a specific, dated fact: Eastman's own 10-K states that 2026 capital spending should fall to about $400 million, down from $546 million, as the recycling build-out finishes and spending shifts to maintenance. That is a mechanical reduction in cash needs, not a bet on stronger demand, and it is the main reason our base case shows owner earnings recovering modestly in 2026 even though the underlying destocking and tariff-related softness may not have fully cleared. From there, our base case assumes the tow destocking works through over the following one to two years — consistent with how the 2022-2023 downturn resolved into a 2024 recovery — lifting owner earnings toward roughly $6.00-6.40 per share by the middle of next decade, with a modest fade in the final years as the acetate tow business continues its long, slow decline in cigarette-filter demand. Beyond the ten-year forecast, we assume a steady, essentially flat level a touch below the year-ten figure: Eastman has spent around $250-255 million a year on R&D for years, and that ongoing investment in specialty products has historically been enough to roughly offset the shrinking tow business, but we are not assuming it becomes a source of real growth beyond that. On this path, we estimate the shares are worth roughly $100 today. Our bear case assumes the tow destocking and tariff-driven softness persist longer than the historical pattern suggests, competition from new Asian capacity keeps pressure on margins, and — the key risk — the recycling investment continues to under-earn the capital put into it. This isn't hypothetical: Eastman's outside auditors flagged a specific reporting unit within Advanced Materials, carrying about $1.3 billion of goodwill, as requiring unusually heavy judgment in this year's fair-value testing — a sign that the economics of that part of the business are being watched closely, even though no impairment has yet been taken. Under this case, owner earnings stay close to the 2022-2023 trough for most of the next decade, and we estimate the shares would be worth roughly $54. Our bull case assumes the guided capital-spending relief comes through in full, the tow destocking resolves on the timeline the last cycle did, and Eastman continues the buyback pace it has actually run for years — diluted share count has fallen from about 136.5 million in 2020 to 115.6 million in 2025 — which lifts per-share value mechanically even without much aggregate growth. We estimate the shares could be worth roughly $119 under this case. Putting these together, given the real uncertainty on both the pace of the cycle and the payoff on the recycling investment, the margin-of-safety price sits at a meaningful discount to our base-case estimate.
Fiscal yearOwner's earningsMethodology
2025 $4.83 ▼
CFO=$970M. WC movement=ΔAR(+61)+ΔInv(+24)+ΔAP(−76)+VarComp(−22)+Other(−113)=−$126M (pension gap −$60M excluded). SBC=$48M. Capex=$546M, the tail of recycling-facility spending; management guides 2026 capex to ~$400M, primarily maintenance, as the build-out completes. 5.6%×revenue($8,752M)=$489.2M<capex, maintenance capex=$489.2M (growth capex=$56.8M). OE=970−(−126)−48−489.2=$558.8M; diluted shares=115.6M; OE/sh=$4.83. Source: FY2025 10-K, accession 0000915389-26-000013.
2024 $5.75 ▼
CFO=$1,287M. WC movement=ΔAR(+28)+ΔInv(−344)+ΔAP(+188)+VarComp(+99)+Other(+51)=+$22M (pension gap −$51M excluded). SBC=$63M. Capex=$599M, still elevated for the recycling build-out; 5.6%×revenue($9,382M)=$524.4M<capex, maintenance capex=$524.4M (growth capex=$74.6M). OE=1287−22−63−524.4=$677.6M; diluted shares=117.9M; OE/sh=$5.75. Source: FY2024 10-K, accession 0000915389-25-000012.
2023 $3.03 ▼
CFO=$1,374M. WC movement=ΔAR(+126)+ΔInv(+201)+ΔAP(−190)+VarComp(+142)+Other(+154)=+$433M (pension gap −$66M excluded; large destocking-driven inventory release). SBC=$64M. Capex=$828M — the peak year of spending on the Kingsport methanolysis (molecular recycling) facility; 5.6%×revenue($9,210M)=$514.7M<capex, so maintenance capex=$514.7M and growth capex=$313.3M, consistent with management's description of this capex as primarily for the recycling build-out. OE=1374−433−64−514.7=$362.3M; diluted shares=119.4M; OE/sh=$3.03 — the cyclical trough of the window, coinciding with the industry-wide chemicals destocking cycle. A one-time $323M non-cash gain on the Texas City divestiture and a $15M gain on asset sales fall in FY2023 (confirmed via XBRL detail); this has no effect on OE since OE is built from CFO, not net income. Source: FY2023 10-K, accession 0000915389-24-000016.
2022 $3.24 ▼
CFO=$975M. WC movement=ΔAR(+93)+ΔInv(−430)+ΔAP(+60)+VarComp(−103)+Other(+290)=−$90M (pension gap −$149M excluded; heavy inventory build amid high feedstock costs). SBC=$69M. Capex=$611M; 5.6%×revenue($10,580M)=$591.4M<capex, maintenance capex=$591.4M (growth capex=$19.6M). OE=975−(−90)−69−591.4=$404.6M; diluted shares=124.9M; OE/sh=$3.24. Source: FY2022 10-K, accession 0000915389-23-000015.
2021 $6.27 ▼
CFO=$1,619M. WC movement=ΔAR(−281)+ΔInv(−389)+ΔAP(+554)+VarComp(+162)+Other(+89)=+$135M (pension gap −$185M excluded; post-COVID demand spike drove a large AR/inventory build funded by a matching AP build). SBC=$70M. Capex=$555M; 5.6%×revenue($10,476M)=$585.5M>capex, maintenance capex=$555M (growth capex=$0 by the ratio test). OE=1619−135−70−555=$859M; diluted shares=137.1M; OE/sh=$6.27. Source: FY2021 10-K, accession 0000915389-22-000010.
2020 $5.69 ▼
CFO=$1,455M. WC movement=ΔAR(−31)+ΔInv(+291)+ΔAP(−100)+VarComp(+87)+Other(+5)=+$252M (pension gap −$136M excluded; COVID-year inventory drawdown was the main driver). SBC=$44M. Capex=$383M; 5.6%×revenue($8,473M)=$473.5M>capex, maintenance capex=$383M (growth capex=$0, revenue declined). OE=1455−252−44−383=$776M; diluted shares=136.5M; OE/sh=$5.69. Source: FY2020 10-K, accession 0000915389-21-000016.
2019 $7.28 ▼
CFO=$1,504M. WC movement=ΔAR(+170)+ΔInv(−80)+ΔAP(−27)+VarComp(+38)+Other(−89)=+$12M (pension gap −$119M excluded). SBC=$59M. Capex=$425M; 5.6%×revenue($9,273M)=$518.2M>capex, so maintenance capex=$425M (growth capex=$0, revenue declined y/y). OE=1504−12−59−425=$1,008M; diluted shares=138.5M; OE/sh=$7.28. Source: FY2019 10-K, accession 0000915389-20-000016.
2018 $6.78 ▼
CFO=$1,543M. WC movement=ΔAR(+16)+ΔInv(−224)+ΔAP(+90)+VarComp(+55)+Other(+45)=−$18M (pension gap −$152M excluded). SBC=$64M. Capex=$528M; 5.6%×revenue($10,151M)=$567.2M>capex, so maintenance capex=full capex=$528M (growth capex=$0). OE=1543−(−18)−64−528=$969M; diluted shares=142.9M; OE/sh=$6.78. Source: FY2018 10-K, accession 0000915389-19-000009.
2017 $5.87 ▼
CFO=$1,657M. WC movement = ΔAR(−53)+ΔInv(−71)+ΔAP(+123)+VarComp(+71)+Other(+144) = +$214M (pension funding gap −$115M excluded, same treatment as all years). SBC=$52M. Capex=$649M; maintenance ratio 5.6%×revenue($9,549M)=$533.7M<capex, maintenance capex=$533.7M (growth capex=$115.3M). OE=1657−214−52−533.7=$857.3M; diluted shares=146.1M; OE/sh=$5.87. Source: FY2017 10-K, accession 0000915389-18-000016.
2016 $6.21 ▼
OE = CFO − WC movement − SBC − maintenance capex. CFO=$1,385M. Working-capital movement = ΔAR(−$29M) + ΔInventory(+$54M) + ΔAP(+$7M) + variable-comp timing(+$17M) + other items(−$125M) = −$76M (pension-funding-in-excess-of-expense of −$329M excluded — treated as a recurring real cash cost, not a reversing WC swing, since it was negative in all 10 years reviewed 2016-2025). SBC=$36M. Capex=$626M; maintenance-capex ratio = mean(capex/revenue) over FY2016–2022 (years before the molecular-recycling capex buildout) = 5.6%; 5.6%×revenue($9,008M)=$503.5M < capex, so maintenance capex=$503.5M (growth capex=$122.5M). OE=1385−(−76)−36−503.5=$921.5M; diluted shares=148.4M; OE/sh=$6.21. Source: FY2016 10-K, accession 0000915389-17-000014.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
Global and not concentrated in any one region. Of 2025 sales, the United States accounted for roughly 42%, China roughly 11%, and all other foreign countries combined roughly 47% — chiefly Europe, other Asia-Pacific markets, and Latin America.
Historical growth strategy

We don't have historical growth strategy information for this company yet.

Chart analysis

We don't have chart analysis for this company yet.

Competitors

We don't have competitor information for this company yet.

Circle of competence

We don't have circle of competence information for this company yet.